激情欧美在线观看丨精品一区二区av丨国产精品久久自在自线不丨欧美精品18videos性欧美丨天堂视频免费丨天天躁日日躁bbbbb丨jizz性欧美15丨欧美牲交a欧美牲交aⅴ久久丨日日干日日草丨永久免费成人丨操操干丨2017天天干天天射丨欧美性性性性xxxxoooo丨久精品国产欧美亚洲色aⅴ大片丨嫩草影院ncyy入口丨婷婷色一区二区三区丨www.youjizz.com国产丨性欧美又大又长又硬丨久久久久久黄丨国产亚洲福利在线视频

歡迎進(jìn)入上海起發(fā)實(shí)驗(yàn)試劑有限公司!
新聞中心
首頁 > 新聞中心 > 熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國代理

熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國代理

 更新時間:2012-11-21 點(diǎn)擊量:2515

 熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國代理!

 

Our Collaborators

NeoClone has focused its business on growing through collaboration.  As we continue to refine our approach to developing fully human antibodies we have partnered with other groups to help validate our system.  Our current collaborators include:

  • University of Wisconsin - Madison, Dr. Manish Patankar, PhD. Dr. Patankar is a noted expert in the area of ovarian cancer and NeoClone is working with him to develop fully human antibodies for the treatment of this devastating disease.
  • University of California - Los Angeles, Dr. Kathie Ferbas, PhD. Dr. Ferbas has an active program for discovering new treatments for AIDS and is working with NeoClone to advance these research goals.
  • InflammatoRx Inc., is an early stage company located in Quebec, Canada. NeoClone is working with InflammatoRx to develop fully human antibodies against their inflammatory biomarker of interest.

NeoClone does have capacity for additional collaboration. Please contact us if this is of interest to you.